Delivery Order SPE2DB24D2010-SPE2DB25FZSS3

Award Date 11/14/24
Potential Completion Date 12/6/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,797.84 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the pharmaceutical product Ibrance 75 mg capsule and has a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, also holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA to provide a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,792.08 firm-fixed-price contract is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The contract has an ultimate completion date of October 3, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ibrance 75 mg tablets. The $7,797.84 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of November 26, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,792.08 Firm Fixed Price Delivery Order contract is for the supply of IBRANCE 125 MG TABLET 7S, a specialty pharmaceutical product. The award has an ultimate completion date of December 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product IBRANCE 125 MG CAPSULE 21S. The $7,792.08 firm fixed price contract was awarded on July 8, 2024 by the Defense Logistics Agency (DLA), with a completion date of July 29, 2024. The contract is a delivery order and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a $7,796.30 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, which has no set-aside designation, is for the delivery of 4564522899 IBRANCE 100 MG TABLET 7S, a pharmaceutical product. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distributor. The order, valued at $7,792.08, is for the supply of 125 mg Ibrance capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,484.74 firm fixed-price delivery order is for the supply of IBRANCE 125 MG CAPSULE 21S, a medical product, with an ultimate completion date of October 31, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,797.84 firm fixed-price delivery order is for the supply of 4565333853 - IBRANCE 75 MG TABLET 7S, a prescription medication. The contract has an ultimate completion date of August 23, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZSS3
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,792.08 firm fixed-price contract is for the delivery of Ibrance 125 mg tablet packages, with a completion date of December 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/13/25, 9:12 AM